| Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade VK Arora, E Schenkein, R Murali, SK Subudhi, J Wongvipat, MD Balbas, ... Cell 155 (6), 1309-1322, 2013 | 990 | 2013 |
| SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ... Science 355 (6320), 84-88, 2017 | 885 | 2017 |
| Androgen receptor signaling regulates DNA repair in prostate cancers WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ... Cancer discovery, 2013 | 525 | 2013 |
| Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer N Shah, P Wang, J Wongvipat, WR Karthaus, W Abida, J Armenia, ... Elife 6, e27861, 2017 | 164 | 2017 |
| Androgen receptor upregulation mediates radioresistance after ionizing radiation DE Spratt, MJ Evans, BJ Davis, MG Doran, MX Lee, N Shah, J Wongvipat, ... Cancer research, canres. 0892.2015, 2015 | 120 | 2015 |
| ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis R Bose, WR Karthaus, J Armenia, W Abida, PJ Iaquinta, Z Zhang, ... Nature 546 (7660), 671, 2017 | 82 | 2017 |
| Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ... Nature communications 12 (1), 1-11, 2021 | 74 | 2021 |
| Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy R Kim, M Kwon, M An, ST Kim, SA Smith, AB Loembé, PGS Mortimer, ... Annals of Oncology, 2021 | 70 | 2021 |
| Characterization of niphatenones that inhibit androgen receptor N-terminal domain CA Banuelos, A Lal, AH Tien, N Shah, YC Yang, NR Mawji, LG Meimetis, ... PloS one 9 (9), e107991, 2014 | 41 | 2014 |
| Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress Y Liao, CH Chen, T Xiao, B de la Peña Avalos, EV Dray, C Cai, S Gao, ... Proceedings of the National Academy of Sciences 119 (3), e2105898119, 2022 | 26 | 2022 |
| Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces MP Caley, H King, N Shah, K Wang, M Rodriguez-Teja, JH Gronau, ... Clinical & experimental metastasis 33 (2), 151-165, 2016 | 25 | 2016 |
| The Sly Oncogene: FOXA1 Mutations in Prostate Cancer N Shah, M Brown Cancer Cell 36 (2), 119-121, 2019 | 20 | 2019 |
| ERG-mediated coregulator complex formation maintains androgen receptor signaling in prostate cancer N Shah, N Kesten, A Font-Tello, MEK Chang, R Vadhi, K Lim, MR Flory, ... Cancer Research, 2020 | 9 | 2020 |
